BamSEC and AlphaSense Join Forces
Learn More

Axm Pharma Inc

Material Contracts Filter

EX-10.2
from 8-K 9 pages Warrant to Purchase Common Stock of Axm Pharma, Inc
12/34/56
EX-10.1
from 8-K 4 pages Separation Agreement
12/34/56
EX-10.1
from 8-K ~50 pages Modification Agreement Dated as of March 1, 2006
12/34/56
EX-10.1
from 8-K 11 pages Transition Agreement
12/34/56
EX-10.1
from 8-K 23 pages Series D Warrant to Purchase Shares of Common Stock of Axm Pharma, Inc. Expires August __, 2010
12/34/56
EX-10.1
from 10-Q 5 pages Consulting Agreement
12/34/56
EX-10.8
from 8-K 14 pages This Agreement Is Made on the [19] of [April] 2005 in [ ] by and Between (1) Axm Pharma (Shenyang), Inc. (The “Mortgagor”), Axm Pharma, Inc. (The “Axm Pharma”)’s Wholly Owned Subsidiary, a Company Incorporated and Validly Existing Under the Laws of Prc; and (2) Each of the Purchasers of the Secured Convertible Promissory Notes of the Axm Pharma Whose Names Are Set Forth on Schedule 2 Attached Hereto (The “Mortgagee”) Whereas: (1) Axm Pharma Has Issued or Will Issue Separate Secured Convertible Promissory Notes (The “Notes”) to the Mortgagee Pursuant to a Note and Warrant Purchase Agreement Dated as of April [19], 2005 (The “Purchase Agreement”), by and Among Axm Pharma and the Mortgagee;; (2) the Mortgagor Has Mortgaged the Mortgaged Property to Pudong Development Bank (The “Pdb”) to Secure the Payment of the Debt With an Amount of Rmb Twenty Million (20,000,000.00) (The “Pdb Debt”); (3) the Mortgagor Agrees to Mortgage the Excess in the Value of Such Mortgaged Property Over the Pdb Debt to Mortgagee to Secure the Performance by Axm Pharma of Its Obligations Under the Purchase Agreement. Now It Is Hereby Agreed as Follows: 1. Definitions and Interpretation 1.1 Definitions
12/34/56
EX-10.7
from 8-K 19 pages Pledge and Security Agreement
12/34/56
EX-10.6
from 8-K 19 pages Series C Warrant to Purchase Shares of Common Stock of Axm Pharma, Inc
12/34/56
EX-10.5
from 8-K 23 pages Series B Warrant to Purchase Shares of Common Stock of Axm Pharma, Inc. Expires April 19, 2010
12/34/56
EX-10.4
from 8-K 23 pages Series a Warrant to Purchase Shares of Common Stock of Axm Pharma, Inc. Expires April 19, 2010
12/34/56
EX-10.3
from 8-K 28 pages Axm Pharma, Inc. Secured Convertible Promissory Note Due April ___ , 2007
12/34/56
EX-10.2
from 8-K/A 7 pages Clause I Mortgaged Property
12/34/56
EX-10.2
from 8-K 19 pages Registration Rights Agreement
12/34/56
EX-10.1
from 8-K 49 pages Note and Warrant Purchase Agreement Dated as of April 19 , 2005 by and Among Axm Pharma, Inc. And
12/34/56
EX-10.17
from 10KSB 3 pages Termination Agreement
12/34/56
EX-10.16
from 10KSB 6 pages Engagement Agreement
12/34/56
EX-10.15
from 10KSB 4 pages This Consulting Agreement (“Agreement”) Is to Be Effective as of September 1, 2004, Entered Into by and Between Axm Pharma, Inc. (“Company”), With Offices Located at 4695 Macarthur Ct. Newport Beach, Ca 92660 and Dreamvest, LLC (“Consultant”), Having Offices at 417 Orchid Ave, Corona Del Mar, Ca 92625. Fact Recitals
12/34/56
EX-10.14
from 10KSB 7 pages Consulting Agreement
12/34/56
EX-10.13
from 10KSB 5 pages Aurelius Consulting Group, Inc Marketing Agreement
12/34/56